Free Trial
→ Palantir and Wall Street are in on it… (From Monument Traders Alliance) (Ad)tc pixel
NYSE:MED

Medifast Q3 2026 Earnings Date & Estimates

Medifast logo
$11.61 0.00 (0.00%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$11.61 +0.00 (+0.01%)
As of 07:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medifast is expected to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. The conference call is scheduled for November 2, 2026 at 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Medifast in Q3 2026

Medifast is expected to post earnings of -$0.35 per share on revenue of $71.30 million. In the same quarter a year earlier Medifast reported -$0.21 per share on revenue of $89.41 million. Medifast last reported on August 3, 2026, posting -$0.28 per share and beating the -$0.65 consensus estimate. Medifast has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.35
Expected Revenue
$71.30 million
Prior-Year EPS
-$0.21
Prior-Year Revenue
$89.41 million
Expected Revenue Growth
-20.3%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.28 (Beat by +$0.37)
Last Quarter Revenue
$76.38 million
EPS Beat Rate
6 of last 8 quarters

Prepare for the Q3 2026 Call

Medifast Q3 2026 Earnings FAQ

Medifast (NYSE:MED) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Medifast's Q3 2026 earnings conference call is scheduled for Monday, November 2, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Medifast to post earnings of -$0.35 per share for Q3 2026.

The consensus revenue estimate for Medifast is $71.30 million for Q3 2026.

Medifast Earnings Headlines

What Actually Keeps Weight Off After a Weight Loss Program
October 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/08/3377113/0/en/what-actually-keeps-weight-off-after-a-weight-loss-program.html
Medifast’s Trilivy Highlights Five Factors That Drive Weight Regain and Its Metabolic Synchronization Framework
October 6, 2026  |  quiverquant.comQ
Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.tc pixel
October 12 at 1:00 AM  |  Weiss Ratings (Ad)
Why Do You Keep Gaining Weight Back After Losing It
October 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/06/3375300/0/en/why-do-you-keep-gaining-weight-back-after-losing-it.html
Bumble, PIMCO Dynamic, Cytokinetics, Medifast, Grace
October 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/weekend-updates/bumble-pimco-dynamic-cytokinetics-medifast-grace?utm_source=marketbeat.com&utm_medium=referral
What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?
October 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/01/3372732/0/en/what-are-the-5-signs-of-poor-metabolic-health-adults-may-overlook.html
See More Medifast Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medifast? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medifast and other key companies, straight to your email.

About Medifast

Medifast (NYSE:MED), Inc. is a health and wellness company that provides weight-management and healthy-living products and services. Its primary brand, OPTAVIA, offers meal replacements, snacks, supplements and other nutrition products designed to support structured weight-management programs.

The company’s programs combine nutrition products with guidance from independent OPTAVIA Coaches. These coaches provide accountability, support and lifestyle guidance intended to help clients develop healthier eating and activity habits.

Medifast was founded in 1980 and is headquartered in Baltimore, Maryland. The company primarily serves customers in the United States through its direct-to-consumer business model and network of independent coaches.

View Medifast Profile
Earnings Tools